Glyceryl Trinitrate Hameln Pharma (Glyceryl Trinitrate Solution)

Glyceryl Trinitrate Hameln Pharma is indicated for several urgent cardiovascular conditions where rapid reduction of cardiac workload is required.

• Management of acute angina pectoris episodes
• Treatment of acute heart failure with pulmonary congestion
• Control of hypertensive emergencies
• Adjunct therapy during myocardial infarction
• Peri‑operative reduction of ischemic risk in cardiac surgery

Side effects of Glyceryl Trinitrate Hameln Pharma vary in frequency and severity.

Common

• Headache, often described as throbbing
• Flushing or warmth of the face and neck
• Hypotension with dizziness or light‑headedness
• Reflex tachycardia
• Nausea or vomiting
• Peripheral edema

Serious

• Severe hypotension leading to syncope
• Methemoglobinemia (rare)
• Acute myocardial ischemia due to coronary steal
• Life‑threatening arrhythmias
• Allergic reactions such as rash or anaphylaxis

Before using Glyceryl Trinitrate Hameln Pharma, clinicians should consider several safety factors.

• Assess baseline blood pressure; avoid use in patients with severe hypotension.
• Contraindicated in patients with known hypersensitivity to organic nitrates.
• Use cautiously in patients with recent phosphodiesterase‑5 inhibitor therapy due to risk of profound hypotension.
• Monitor for signs of methemoglobinemia, especially in patients with G6PD deficiency.
• Adjust dosage in patients with impaired hepatic function, as metabolism may be reduced.
• Ensure continuous cardiac monitoring during intravenous infusion.

Glyceryl Trinitrate Hameln Pharma can interact with several drug classes, requiring careful management.

Avoid

• Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil) because of additive vasodilatory effects.
• Other potent vasodilators such as hydralazine or calcium channel blockers that may cause severe hypotension.
• Alcohol or other central nervous system depressants that can exacerbate blood pressure drops.

Use with caution

• Antihypertensive agents (beta‑blockers, ACE inhibitors) – monitor blood pressure closely.
• Diuretics – may increase risk of volume depletion and hypotension.
• Drugs affecting hepatic metabolism (e.g., azole antifungals) – may alter nitrate clearance.
• Anesthetics used during surgery – coordinate dosing to avoid excessive vasodilation.